Literature DB >> 18353896

Phosphorylation of beta-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells.

Sebastien Taurin1, Nathan Sandbo, Douglas M Yau, Nan Sethakorn, Nickolai O Dulin.   

Abstract

Extracellular ATP stimulates proliferation of vascular smooth muscle cells (VSMC) through activation of G protein-coupled P2Y purinergic receptors. We have previously shown that ATP stimulates a transient activation of protein kinase A (PKA), which, together with the established mitogenic signaling of purinergic receptors, promotes proliferation of VSMC (Hogarth DK, Sandbo N, Taurin S, Kolenko V, Miano JM, Dulin NO. Am J Physiol Cell Physiol 287: C449-C456, 2004). We also have shown that PKA can phosphorylate beta-catenin at two novel sites (Ser552 and Ser675) in vitro and in overexpression cell models (Taurin S, Sandbo N, Qin Y, Browning D, Dulin NO. J Biol Chem 281: 9971-9976, 2006). beta-Catenin promotes cell proliferation by activation of a family of T-cell factor (TCF) transcription factors, which drive the transcription of genes implicated in cell cycle progression including cyclin D1. In the present study, using the phosphospecific antibodies against phospho-Ser552 or phospho-Ser675 sites of beta-catenin, we show that ATP can stimulate PKA-dependent phosphorylation of endogenous beta-catenin at both of these sites without affecting its expression levels in VSMC. This translates to a PKA-dependent stimulation of TCF transcriptional activity through an increased association of phosphorylated (by PKA) beta-catenin with TCF-4. Using the PKA inhibitor PKI or dominant negative TCF-4 mutant, we show that ATP-induced cyclin D1 promoter activation, cyclin D1 protein expression, and proliferation of VSMC are all dependent on PKA and TCF activities. In conclusion, we show a novel mode of regulation of endogenous beta-catenin through its phosphorylation by PKA, and we demonstrate the importance of this mechanism for ATP-induced proliferation of VSMC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18353896      PMCID: PMC3327159          DOI: 10.1152/ajpcell.00096.2008

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  32 in total

Review 1.  Purinergic signaling and vascular cell proliferation and death.

Authors:  Geoffrey Burnstock
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

2.  Functional P2Y2 nucleotide receptors mediate uridine 5'-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries.

Authors:  Cheikh I Seye; Qiongman Kong; Laurie Erb; Richard C Garrad; Brent Krugh; Meifang Wang; John T Turner; Michael Sturek; Fernando A González; Gary A Weisman
Journal:  Circulation       Date:  2002-11-19       Impact factor: 29.690

Review 3.  Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development.

Authors:  Stefan E Hardt; Junichi Sadoshima
Journal:  Circ Res       Date:  2002-05-31       Impact factor: 17.367

Review 4.  P2 receptors: new potential players in atherosclerosis.

Authors:  Francesco Di Virgilio; Anna Solini
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

5.  A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling.

Authors:  Xiaohong Wang; Yan Xiao; Yongshan Mou; Ying Zhao; W Matthijs Blankesteijn; Jennifer L Hall
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

6.  Downregulation of smooth muscle alpha-actin expression by bacterial lipopolysaccharide.

Authors:  Nathan Sandbo; Sebastien Taurin; Douglas M Yau; Steven Kregel; Richard Mitchell; Nickolai O Dulin
Journal:  Cardiovasc Res       Date:  2007-01-18       Impact factor: 10.787

7.  Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation.

Authors:  J R Alt; J L Cleveland; M Hannink; J A Diehl
Journal:  Genes Dev       Date:  2000-12-15       Impact factor: 11.361

Review 8.  Potential therapeutic targets in the rapidly expanding field of purinergic signalling.

Authors:  G Burnstock
Journal:  Clin Med (Lond)       Date:  2002 Jan-Feb       Impact factor: 2.659

9.  Wnt signaling controls the phosphorylation status of beta-catenin.

Authors:  Mascha van Noort; Jan Meeldijk; Ruurd van der Zee; Olivier Destree; Hans Clevers
Journal:  J Biol Chem       Date:  2002-02-07       Impact factor: 5.157

10.  Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth. Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor.

Authors:  Evgenia V Gerasimovskaya; Shama Ahmad; Carl W White; Peter L Jones; Todd C Carpenter; Kurt R Stenmark
Journal:  J Biol Chem       Date:  2002-09-18       Impact factor: 5.157

View more
  31 in total

1.  Tri-iodothyronine induces hepatocyte proliferation by protein kinase A-dependent β-catenin activation in rodents.

Authors:  Maura Fanti; Sucha Singh; Giovanna M Ledda-Columbano; Amedeo Columbano; Satdarshan P Monga
Journal:  Hepatology       Date:  2014-04-14       Impact factor: 17.425

2.  Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals.

Authors:  Chun-Chun Li; Kang Le; Jiro Kato; Joel Moss; Martha Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

3.  Cytoskeletal mechanisms regulating vascular endothelial barrier function in response to acute lung injury.

Authors:  Anita Kása; Csilla Csortos; Alexander D Verin
Journal:  Tissue Barriers       Date:  2015-04-03

4.  Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation.

Authors:  Jun Guo; Minlin Liu; Dehong Yang; Mary L Bouxsein; Hiroaki Saito; R J Sells Galvin; Stuart A Kuhstoss; Clare C Thomas; Ernestina Schipani; Roland Baron; F Richard Bringhurst; Henry M Kronenberg
Journal:  Cell Metab       Date:  2010-02-03       Impact factor: 27.287

5.  Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells.

Authors:  X Sun; C Xu; S-C Tang; J Wang; H Wang; P Wang; N Du; S Qin; G Li; S Xu; Z Tao; Dapeng Liu; H Ren
Journal:  Cancer Gene Ther       Date:  2016-03-18       Impact factor: 5.987

6.  Prostaglandin-mediated inhibition of PTH-stimulated β-catenin signaling in osteoblasts by bone marrow macrophages.

Authors:  Thomas L Estus; Shilpa Choudhary; Carol C Pilbeam
Journal:  Bone       Date:  2016-02-03       Impact factor: 4.398

Review 7.  Vasopressin-2 receptor signaling and autosomal dominant polycystic kidney disease: from bench to bedside and back again.

Authors:  Markus M Rinschen; Bernhard Schermer; Thomas Benzing
Journal:  J Am Soc Nephrol       Date:  2014-02-20       Impact factor: 10.121

8.  Hypoglycosylated hFSH Has Greater Bioactivity Than Fully Glycosylated Recombinant hFSH in Human Granulosa Cells.

Authors:  Chao Jiang; Xiaoying Hou; Cheng Wang; Jeffrey V May; Viktor Y Butnev; George R Bousfield; John S Davis
Journal:  J Clin Endocrinol Metab       Date:  2015-04-27       Impact factor: 5.958

9.  Positive cross talk between protein kinase D and β-catenin in intestinal epithelial cells: impact on β-catenin nuclear localization and phosphorylation at Ser552.

Authors:  Jia Wang; Liang Han; James Sinnett-Smith; Li-Li Han; Jan V Stevens; Nora Rozengurt; Steven H Young; Enrique Rozengurt
Journal:  Am J Physiol Cell Physiol       Date:  2016-01-06       Impact factor: 4.249

10.  Convergence of 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A and glycogen synthase kinase-3beta/beta-catenin signaling in corpus luteum progesterone synthesis.

Authors:  Lynn Roy; Claudia A McDonald; Chao Jiang; Dulce Maroni; Anthony J Zeleznik; Todd A Wyatt; Xiaoying Hou; John S Davis
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.